菲卓替尼
Fedratinib | TG-101348 | SAR 302503
ChemLeader
Catalog No:
CAS No.:
MDLNo:
Formula:
MW:
Size
Quantity
- +
Product Overview
Product Name Fedratinib | TG-101348 | SAR 302503
CAS936091-26-8
FormulaC27H36N6O3S
MW524.68
AppearanceWhite to light yellow powder
Storage conditionDry, dark and at 0 - 4 ℃ for short term (days to weeks) or -20 ℃ for long term (months to years).
Security information
Product details

 Fedratinib, also known as TG101348 and SAR302503, is a JAK2 inhibitor, is also an orally bioavailable, small-molecule, ATP-competitive inhibitor of Janus-associated kinase 2 (JAK2) with potential antineoplastic activity. JAK2 inhibitor TG101348 competes with JAK2 as well as the mutated form AK2V617F for ATP binding, which may result in inhibition of JAK2 activation, inhibition of the JAK-STAT signaling pathway, and the induction of tumor cell apoptosis. JAK2 is the most common mutated gene in bcr-abl-negative myeloproliferative disorders (MPDs); the mutated form JAK2V617F has a valine-to-phenylalanine modification at position 617 and plays a key role in tumor cell proliferation and survival.

Related literature
Related
Sorry, no related items
History
(E/Z)-BIX02188
Fedratinib | TG-101348 | SAR 302503
L-742001 hydrochloride
TetrahydroaMentoflavone
Deucravacitinib (Synonyms: BMS-986165)
4-(Methylamino)phenol hemisulfate (Metol)
Darunavir (TMC114)
Recilisib | ON 01210 | EX-RAD
Toddalosin
Ritodrine